GSK hepatitis C shot shows promise, bodes well for Ebola vaccines

November 5, 2014 7:20 PM

7 0

GSK hepatitis C shot shows promise, bodes well for Ebola vaccines

Highest paid women in music

LONDON (Reuters) - A new hepatitis C vaccine from GlaxoSmithKline based on the same technology as an experimental Ebola shot being fast-tracked through human trials has shown promise in early clinical tests, prompting strong and broad immune responses.

Read more

To category page

Loading...